23:55 , Dec 5, 2018 |  BC Extra  |  Financial News

Burrill gets 30 months in prison for fraud

A federal court sentenced G. Steven Burrill to 30 months in prison for tax evasion and defrauding investors in a scheme to siphon money from the Burrill Life Sciences Capital Fund III. The U.S. District...
21:30 , Sep 29, 2017 |  BC Week In Review  |  Financial News

Burrill indicted for fraud

On Sept. 18, a federal grand jury in San Francisco indicted G. Steven Burrill on 31 counts of fraud related to an investment fund scheme. The U.S. Department of Justice said Burrill is charged with...
01:25 , Sep 21, 2017 |  BC Extra  |  Financial News

Burrill indicted for fraud

On Monday, a federal grand jury in San Francisco indicted G. Steven Burrill on 31 counts of fraud related to an investment fund scheme. The U.S. Department of Justice said Burrill is charged with 26...
01:23 , Apr 1, 2016 |  BC Extra  |  Financial News

Burrill settles with SEC, accepts permanent ban

G. Steven Burrill and two other members of Burrill Capital Management's team agreed to be barred permanently from the securities industry to settle an SEC investigation into Burrill's alleged embezzlement from the 2006-vintage, $283 million...
01:25 , Jul 14, 2015 |  BC Extra  |  Financial News

LPs go after Burrill

Burrill Life Sciences Capital Fund III L.P. filed a lawsuit alleging that G. Steven Burrill, Burrill & Co. and members of the firm's management team embezzled more than $17 million from Fund III between 2007...
08:00 , Mar 2, 2015 |  BC Week In Review  |  Financial News

Neos Therapeutics completes venture financing

Neos Therapeutics Inc. , Grand Prairie, Texas   Business: Drug delivery, Neurology   Date completed: 2015-02-25   Type: Venture financing   Raised: $20.6 million   Investors: Presidio Partners; Crabtree Partners; CAC LLC; Delaware Street Capital;...
00:56 , Jun 19, 2014 |  BC Extra  |  Financial News

Suit details allegations against Burrill, associates

G. Steven Burrill has been named in a California lawsuit that details allegations that Burrill & Co. and members of its management improperly diverted funds from Burrill Life Sciences Capital Fund III L.P. The suit,...
07:00 , Mar 10, 2014 |  BC Week In Review  |  Financial News

Neos Therapeutics completes venture financing

Neos Therapeutics Inc. , Grand Prairie, Texas   Business: Drug delivery, Neurology   Date completed: 3/4/14   Type: Venture financing   Raised: $15.5 million   Investors: Burrill Life Sciences Capital Fund III; CAC; CMEA Capital;...
08:00 , Jan 2, 2006 |  BioCentury  |  Finance

Ebb & Flow

Perlegen is remaining mum on when and if it will test the IPO waters, but there's a clear incentive for the company to join the public space this year. That's because the personalized medicine and...
08:00 , Jan 10, 2005 |  BioCentury  |  Finance

Ebb & Flow

Last week saw two series D rounds go in opposite directions. Cancer play Nereus opted for a two-part financing, and maintains that having milestone-contingent money is important for discipline. On the flip side, drug delivery...